Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty
NCT ID: NCT02299271
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
72 participants
INTERVENTIONAL
2014-06-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine
NCT07316166
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty
NCT00864409
EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture
NCT03955458
Hip Arthroscopy Pain Control Randomized Control Trial (RCT)
NCT02947178
Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty
NCT02359136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This prospective, double-blinded, randomized, single-center study is designed to test the primary hypothesis that fascia iliaca block with a local anesthestic decreases narcotic consumption and provides improved pain control compared to placebo in the first 24 hours after surgery in patients undergoing total hip arthroplasty.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ropivacaine block
Ropivacaine 0.375% as a one-time 60 milliliter injection.
Ropivacaine
0.375% ropivacaine as a one-time, 60 milliliter injection
saline block
Sodium chloride 0.9% as a one-time 60 milliliter injection.
Saline
Saline as a one-time, 60 milliliter injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine
0.375% ropivacaine as a one-time, 60 milliliter injection
Saline
Saline as a one-time, 60 milliliter injection.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
* age 18 to 75 years
* American Society of Anesthesiologists (ASA) physical status 1 to 3
* BMI \< 40 kg/m2
* Minimum weight of 50 kg.
* No contraindications to study procedures
Exclusion Criteria
* Allergy to local anesthetics
* Allergy to oxycontin
* Allergy to pregabalin
* Allergy to fentanyl
* Allergy to midazolam
* Allergy to hydromorphone
* BMI \> 40 kg/m2
* Chronic pre-operative opioid use
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Christ Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian Vaughan
Brian Vaughan, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian Vaughan, MD
Role: PRINCIPAL_INVESTIGATOR
The Christ Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Christ Hospital
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shariat AN, Hadzic A, Xu D, Shastri U, Kwofie K, Gandhi K, McCally CM, Gratenstein K, Vandepitte C, Gadsden J, Unis D. Fascia lliaca block for analgesia after hip arthroplasty: a randomized double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2013 May-Jun;38(3):201-5. doi: 10.1097/AAP.0b013e31828a3c7c.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Christh-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.